Towerpoint Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Buy
4,871
+86
+2% +$18.5K 0.42% 42
2026
Q1
$1.04M Sell
4,785
-3
-0.1% -$665 0.42% 42
2025
Q4
$1.09M Buy
4,788
+3
+0.1% +$683 0.43% 41
2025
Q3
$1.11M Sell
4,785
-63
-1% -$12.8K 0.45% 40
2025
Q2
$900K Hold
4,848
0.4% 43
2025
Q1
$1.02M Sell
4,848
-487
-9% -$94.7K 0.5% 37
2024
Q4
$948K Hold
5,335
0.46% 37
2024
Q3
$1.05M Hold
5,335
0.5% 34
2024
Q2
$915K Buy
5,335
+332
+7% +$55K 0.46% 36
2024
Q1
$911K Buy
5,003
+304
+6% +$52.4K 0.46% 36
2023
Q4
$728K Buy
4,699
+5
+0.1% +$729 0.4% 40
2023
Q3
$700K Sell
4,694
-82
-2% -$12K 0.42% 42
2023
Q2
$643K Buy
4,776
+26
+0.5% +$3.81K 0.36% 43
2023
Q1
$757K Buy
4,750
+464
+11% +$70.9K 0.43% 42
2022
Q4
$693K Buy
4,286
+42
+1% +$6.44K 0.4% 42
2022
Q3
$570K Hold
4,244
0.34% 47
2022
Q2
$650K Hold
4,244
0.39% 45
2022
Q1
$688K Sell
4,244
-75
-2% -$10.9K 0.34% 45
2021
Q4
$585K Hold
4,319
0.28% 45
2021
Q3
$466K Sell
4,319
-50
-1% -$5.71K 0.23% 46
2021
Q2
$492K Buy
4,369
+25
+0.6% +$2.82K 0.24% 47
2021
Q1
$470K Buy
+4,344
New +$465K 0.23% 48

Other funds holding ABBV

Towerpoint Wealth's ABBV Position: Q2 2026 in Review

Towerpoint Wealth increased its AbbVie (ABBV) stake by 1.8% in Q2 2026, buying an estimated $18.5K and bringing the position to 4,871 shares worth $1.23M. The position accounts for 0.42% of the portfolio, ranked #42.

Towerpoint Wealth first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. 1,742 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Towerpoint Wealth held 4,871 shares of AbbVie worth $1.23M as of Q2 2026.
  • Towerpoint Wealth bought 86 AbbVie shares in Q2 2026, an estimated $18.5K.
  • AbbVie made up 0.42% of Towerpoint Wealth's portfolio in Q2 2026, its #42 holding.
  • Towerpoint Wealth first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
  • 1,742 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Towerpoint Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.